Login / Signup

Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice.

Florine A BergerHeleen van der SijsMatthijs L BeckerTeun van GelderPatricia M L A van den Bemt
Published in: BMC medical informatics and decision making (2020)
No trial registration, MEC-2015-368.
Keyphrases
  • clinical practice
  • drug induced
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • adverse drug
  • randomized controlled trial
  • emergency department